Experiment 376512

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVO

Compounds isolated

BERBAMINE

Details

PropertyValue
Pharmacology
DELAYED TYPE CUTANEOUS HYPERSENSITIVITY INHIBITION
Administration routeIP
OrganismEmpty organism
CitationLUO,CN: LIN,X: LI,WK: YANG,XW: XIE,SS: XIAO,PG:. (1997). STUDY ON THE IMMUNOSUPPRESSIVE EFFECTS OF BERBAMINE AND ITS MECHANISM.. 11(8)
Amount utilized
Compound isolated
DiseaseVS.ALLOGENIC ANTIGEN-INDUCED ALLERGIC RESPONSE.
Dose amount50.0 MG
Number3
Qualitative resultACTIVE
AnimalMOUSE
Per unitKG
Dose expressionDOSE
GenderFEMALE